Article: ALLEGRA-D(R) 24 Hour (fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg) Extended Release Tablets Now Available for Seasonal Allergy Sufferers.

Once-daily formulation provides 24-hour relief of seasonal allergy symptoms with nasal congestion

BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that Allegra-D(R) 24 Hour (fexofenadine HCl 180 mg/pseudophedrine HCl 240 mg) Extended-Release Tablets are now available for the treatment of seasonal allergy symptoms with nasal congestion in adults and children 12 years of age and older. Allegra-D 24 Hour provides allergy patients with the power of once-daily Allegra (fexofenadine HCl) 180 mg, combined with 24-hour relief from nasal congestion, in a convenient, once- daily tablet. Allegra-D 24 Hour is an addition to the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!